A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2011
05/24/2011	CA2497569C 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
05/24/2011	CA2490888C Diaminopyrimidinecarboxamide derivative
05/24/2011	CA2490239C Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
05/24/2011	CA2477601C 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
05/24/2011	CA2467552C Nicotin-or isonicotin benzothiazole derivatives
05/24/2011	CA2453901C Substituted 4-aminocyclohexanols
05/24/2011	CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
05/24/2011	CA2440596C Soluble heterodimeric cytokine receptor
05/24/2011	CA2439787C Nitrogen-based camptothecin derivatives
05/24/2011	CA2393710C Caspase inhibitors and uses thereof
05/24/2011	CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/24/2011	CA2344816C Medicinal aerosol formulation
05/24/2011	CA2323072C Gfr.alpha.3 and its uses
05/24/2011	CA2266640C Methods for treating an ischemic disorder and improving stroke outcome
05/24/2011	CA2229631C Gene therapy using ovine adenoviral vectors
05/19/2011	WO2011059731A1 Alkynyl derivatives useful as dpp-1 inhibitors
05/19/2011	WO2011059080A1 Isotope-substituted diamine derivative
05/19/2011	WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
05/19/2011	WO2011058943A1 Pharmaceutical composition formed from combining compound having mch r1 antagonist activity and compound having npy y5 antagonist activity
05/19/2011	WO2011058764A1 Gargle preparation, and process and apparatus for production of same
05/19/2011	WO2011058374A1 Drug combination with theobromine and its use in therapy
05/19/2011	WO2011058346A1 Treatment of microbial infections
05/19/2011	WO2011024056A3 An improved process for the preparation of bosentan
05/19/2011	WO2010151784A3 Antimicrobial compounds
05/19/2011	US20110118825 Anti-angiogenic compositions and methods of use
05/19/2011	US20110118362 Polymers for cardiopulmonary therapies
05/19/2011	US20110118358 Deuterium-enriched salmeterol
05/19/2011	US20110118354 Cyclohexenyl modulators of chemokine receptor activity
05/19/2011	US20110118341 Long term disease modification using immunostimulatory oligonucleotides
05/19/2011	US20110118315 5-lipoxygenase-activating protein (flap) inhibitors
05/19/2011	US20110118287 Bicycloheteroaryl Compounds As P2X7 Modulators and Uses Thereof
05/19/2011	US20110118284 Thienopyrimidine compounds
05/19/2011	US20110118282 Soluble Guanylate Cyclase Activators
05/19/2011	US20110118273 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds
05/19/2011	US20110118271 Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases
05/19/2011	US20110118268 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators
05/19/2011	US20110118265 Use of anti-bacterial agents for the treatment of epithelial-related conditions
05/19/2011	US20110118257 Novel kinase modulators
05/19/2011	US20110118248 Heteroaryl sulfonamides and CCR2/CCR9
05/19/2011	US20110118246 Novel Compounds
05/19/2011	US20110118223 Novel quinuclidine derivatives and medicinal compositions containing the same
05/19/2011	US20110118221 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use
05/19/2011	US20110118201 Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed
05/19/2011	US20110118198 Polysulfated glycosides and salts thereof
05/19/2011	US20110118186 Synthetic peptide amides and dimeric forms thereof
05/19/2011	US20110117569 Polymide nucleic acid derivatives, and agents and processes for preparing them
05/19/2011	US20110117213 Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom
05/19/2011	US20110117191 Mixture of substances on the basis of a mixture of essential oils and use
05/19/2011	US20110117159 Inhibition of jak2 as a treatment of pulmonary arterial hypertension
05/19/2011	US20110117115 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders
05/19/2011	US20110117113 Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them
05/19/2011	US20110117112 Sodium channel protein type iii alpha-subunit splice variant
05/19/2011	US20110117106 Uses of calpain inhibitors to inhibit inflammation
05/19/2011	US20110117103 Anti-sweat antigen monoclonal antibody
05/19/2011	US20110117102 Therapeutic uses of inhibitors of RTP801
05/19/2011	US20110117077 Nutritional composition for infants delivered via caesarean section
05/19/2011	US20110117073 Protein Kinase Conjugates and Inhibitors
05/19/2011	US20110117030 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections
05/19/2011	US20110117021 Fully human anti-vap-1 monoclonal antibodies
05/19/2011	DE102009053089A1 Stoffgemisch auf Basis einer Misching von ätherischen Ölen und Verwendung Mixture based on a Misching of essential oils and use
05/19/2011	CA2780704A1 Drug combination with theobromine and its use in therapy
05/19/2011	CA2780703A1 Drug combination with theobromine and its use in therapy
05/19/2011	CA2780614A1 Treatment of microbial infections
05/19/2011	CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
05/18/2011	EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy
05/18/2011	EP2322545A1 Analogues of GLP-1
05/18/2011	EP2322522A1 New tiotropium salts, processes for their preparation and drug formulations containing them
05/18/2011	EP2322521A1 Heteroaryl compounds useful as inhibitors of GSK-3
05/18/2011	EP2322501A1 4-dedimethylamino tetracycline compounds
05/18/2011	EP2322243A1 Pharmaceutical products and compositions comprising formoterol, ciclesonide and tiotropium
05/18/2011	EP2322218A1 Methods of modulating CD200 receptors
05/18/2011	EP2322189A2 Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
05/18/2011	EP2322174A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes
05/18/2011	EP2322169A1 Composition containing a DHA oil for use in the treatment of cystic fibrosis
05/18/2011	EP2321268A2 Bi-aryl aminotetralines
05/18/2011	EP2321267A2 Monoaryl aminotetralines
05/18/2011	EP2321266A2 Substituted aminotetralines
05/18/2011	EP2320916A2 Antihistamine and antihistamine-like nasal application, products, and method
05/18/2011	EP2320899A1 Dihydrotetrabenazine for treatment of asthma
05/18/2011	EP2320878A1 Monoterpenes for treating respiratory tract diseases, in particular bronchopulmonary diseases
05/18/2011	EP1529053B1 Macrolide compounds endowed with antiinflammatory activity
05/18/2011	EP1268096B9 Extrusion die
05/18/2011	CN1913873B Medical product containing tiotropium incorporated in a waterproof container
05/18/2011	CN102066412A Treatment of diseases and conditions mediated by eicosanoids
05/18/2011	CN102066385A New peptidomimetic compounds
05/18/2011	CN102066358A CGRP receptor antagonists
05/18/2011	CN102066330A Polymorph of 8-hydroxy-5- [(1R)-1-hydroxy-2- [[(1R) -2-(4-methoxyphenyl) -1-methylethyl] amino] ethyl] -2(1H)-quinolinone monohydrochloride
05/18/2011	CN102066329A Crystal form of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2- (4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)- quinolinone monohydrochloride
05/18/2011	CN102066317A Substituted aminotetralines
05/18/2011	CN102065869A Antiallergic marine biopolymers
05/18/2011	CN102065850A Electrostatically charged nasal application multipurpose product and method
05/18/2011	CN102061306A Preparation method and application of immunomodulatory peptide
05/18/2011	CN102060929A T-cell immune balance peptide
05/18/2011	CN102060857A Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/18/2011	CN102060842A 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition
05/18/2011	CN102060809A Rhein derivatives and preparation and application thereof
05/18/2011	CN102058892A Material mixture based on a mixture of ether oils and use of same
05/18/2011	CN102058888A Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof
05/18/2011	CN102058880A Method for producing trivalent inactivated vaccines for porcine infectious pleuropneumonia
05/18/2011	CN102058865A Traditional Chinese medicinal preparation for treating stable-phase chronic obstructive pulmonary disease

1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 878